| Primary |
| Drug Use For Unknown Indication |
36.6% |
| Product Used For Unknown Indication |
14.2% |
| Helicobacter Infection |
10.7% |
| Antibiotic Prophylaxis |
4.3% |
| Mycobacterial Infection |
4.2% |
| Atypical Mycobacterial Infection |
3.8% |
| Mycobacterium Avium Complex Infection |
3.8% |
| Helicobacter Gastritis |
3.0% |
| Hiv Infection |
2.2% |
| Tonsillitis |
2.2% |
| Tuberculosis |
2.2% |
| Bronchitis |
1.8% |
| Cough |
1.7% |
| Gastroduodenal Ulcer |
1.7% |
| Hypertension |
1.7% |
| Arthralgia |
1.3% |
| Lung Disorder |
1.3% |
| Giardiasis |
1.2% |
| Pyrexia |
1.2% |
| Infective Tenosynovitis |
1.0% |
|
| Vertigo |
10.4% |
| Pyrexia |
9.0% |
| Weight Decreased |
9.0% |
| Vomiting |
7.5% |
| Septic Shock |
6.0% |
| Thrombocytopenia |
6.0% |
| Toxic Skin Eruption |
6.0% |
| Uveitis |
6.0% |
| Cutaneous Vasculitis |
4.5% |
| Prothrombin Time Shortened |
4.5% |
| Weight Increased |
4.5% |
| Drug Interaction |
3.0% |
| Hepatic Enzyme Increased |
3.0% |
| Inflammation |
3.0% |
| Melaena |
3.0% |
| Multi-organ Failure |
3.0% |
| Oesophageal Candidiasis |
3.0% |
| Optic Neuritis |
3.0% |
| Overdose |
3.0% |
| Rash Papular |
3.0% |
|
| Secondary |
| Product Used For Unknown Indication |
21.1% |
| Drug Use For Unknown Indication |
11.8% |
| Helicobacter Infection |
7.9% |
| Hiv Infection |
7.9% |
| Bronchopneumopathy |
6.8% |
| Tuberculosis |
5.6% |
| Mycobacterial Infection |
5.4% |
| Atypical Mycobacterial Infection |
5.2% |
| Mycobacterium Avium Complex Infection |
4.4% |
| Ill-defined Disorder |
3.9% |
| Antibiotic Prophylaxis |
3.4% |
| Bronchopulmonary Aspergillosis |
3.0% |
| Duodenal Ulcer |
2.7% |
| Aspergillosis |
1.7% |
| Infection |
1.7% |
| Odynophagia |
1.7% |
| Gastroduodenal Ulcer |
1.5% |
| Lung Disorder |
1.5% |
| Hypertension |
1.4% |
| Pneumonia Legionella |
1.4% |
|
| Weight Increased |
13.0% |
| Pyrexia |
8.7% |
| Renal Failure Acute |
7.6% |
| Toxic Skin Eruption |
7.6% |
| Rash Pustular |
5.4% |
| Immune Reconstitution Syndrome |
4.3% |
| Optic Neuritis |
4.3% |
| Rash Maculo-papular |
4.3% |
| Septic Shock |
4.3% |
| Thrombocytopenia |
4.3% |
| Urticaria |
4.3% |
| Vertigo |
4.3% |
| Vomiting |
4.3% |
| Cytolytic Hepatitis |
3.3% |
| Hepatic Enzyme Increased |
3.3% |
| Hepatitis |
3.3% |
| Pseudomembranous Colitis |
3.3% |
| Rash |
3.3% |
| Rash Papular |
3.3% |
| Subdural Haematoma |
3.3% |
|
| Concomitant |
| Hiv Infection |
25.3% |
| Drug Use For Unknown Indication |
14.2% |
| Mycobacterium Avium Complex Infection |
11.6% |
| Disseminated Tuberculosis |
6.8% |
| Mycobacterial Infection |
6.2% |
| Atypical Mycobacterial Infection |
6.0% |
| Antifungal Prophylaxis |
4.6% |
| Prophylaxis |
4.4% |
| Tuberculosis |
2.6% |
| B-cell Lymphoma |
2.0% |
| Fungal Infection |
2.0% |
| Anaemia |
1.8% |
| Antiviral Prophylaxis |
1.8% |
| Hypertension |
1.6% |
| Insomnia |
1.6% |
| Nausea |
1.6% |
| Pain |
1.6% |
| Supplementation Therapy |
1.6% |
| Immune Reconstitution Syndrome |
1.4% |
| Breast Cancer |
1.2% |
|
| Subdural Haematoma |
16.7% |
| Pyrexia |
11.1% |
| Vomiting |
11.1% |
| Tubulointerstitial Nephritis |
8.3% |
| Hepatitis Fulminant |
4.2% |
| Lymphadenitis |
4.2% |
| Rash |
4.2% |
| Rash Pruritic |
4.2% |
| Renal Failure |
4.2% |
| Renal Tubular Disorder |
4.2% |
| Fracture |
2.8% |
| Mouth Ulceration |
2.8% |
| Neutropenia |
2.8% |
| Pregnancy |
2.8% |
| Refractory Anaemia |
2.8% |
| Renal Failure Acute |
2.8% |
| Thrombocytopenia |
2.8% |
| Toxic Skin Eruption |
2.8% |
| Tuberculosis Liver |
2.8% |
| Vaginal Ulceration |
2.8% |
|
| Interacting |
| Drug Use For Unknown Indication |
20.0% |
| Mycobacterial Infection |
20.0% |
| Prophylaxis |
20.0% |
| Arthralgia |
7.5% |
| Hiv Infection |
7.5% |
| Hypertension |
7.5% |
| Antibiotic Prophylaxis |
2.5% |
| Gastric Ulcer |
2.5% |
| Gastrointestinal Haemorrhage |
2.5% |
| Helicobacter Infection |
2.5% |
| Mycobacterium Avium Complex Infection |
2.5% |
| Product Used For Unknown Indication |
2.5% |
| Type 2 Diabetes Mellitus |
2.5% |
|
| Overdose |
33.3% |
| Drug Interaction |
16.7% |
| Hypokalaemia |
16.7% |
| Shock |
16.7% |
| Weight Decreased |
16.7% |
|
